Nutex Health Inc.
NUTX
Positions held
Your positionsNUTX isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Nutex Health Inc. is strategically positioned in the healthcare sector, focusing on medical care facilities, which are essential in a growing aging population and increasing healthcare demands.
- In the latest quarter, Nutex reported a gross margin of 67%, significantly up from 42.4% in the prior quarter, indicating improved operational efficiency.
- The company's operating margin expanded to 57.8%, showcasing strong profitability potential as it continues to optimize its operations.
- Despite its strong operational metrics, Nutex has experienced a revenue decline of 3% compared to the previous quarter, raising concerns about its growth trajectory.
- The company reported a revenue growth of -13.6% year-over-year, highlighting challenges in maintaining consistent revenue streams.
- Nutex's current debt-to-equity ratio stands at 68.47, which may pose risks in terms of financial stability and leverage.
Fundamentals
| Market cap | $1.40B | Enterprise value | $1.66B | Trailing P/E | 8.12 | Forward P/E | 10.08 |
| PEG | — | Price / book | 3.56 | Beta | 2.00 | Dividend yield | 0.00% |
| Revenue growth | -13.6% | Earnings growth | — | Gross margin | 54.5% | Operating margin | 57.8% |
| Profit margin | 21.2% | ROE | 64.6% | ROA | 33.3% | Debt / equity | 0.68 |
| Current ratio | 5.00 | Free cash flow | $130.75M | Analyst recommendation | strong_buy | Mean target | $288.20 |
| 52w high | $226.16 | 52w low | $83.99 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $211M | $216M | $152M | $268M | $244M | — |
| Op margin | 57.8% | 37.5% | 20.4% | 48.7% | 13.8% | — |
| Net income | $65.8M | $46.8M | $11.8M | $55.4M | -$17.7M | — |
| Gross margin | 67.0% | 42.4% | 30.4% | 57.8% | 51.2% | — |
| Gross profit | $141M | $91.7M | $46.1M | $155M | $125M | — |
| Operating income | $122M | $81.3M | $30.9M | $130M | $33.7M | — |
- Revenue -3% vs prior quarter ($211M vs $216M).
- Gross margin 67% (was 42.4% prior quarter).
- Operating margin expanded to 57.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $875M | $480M | $248M | $219M |
| Op margin | 31.5% | 28.7% | -0.6% | -2.1% |
| Net income | $70.8M | $52.1M | -$45.8M | -$425M |
| Gross margin | 50.8% | 40.9% | 14.0% | 7.0% |
| Gross profit | $444M | $196M | $34.8M | $15.4M |
| Operating income | $276M | $138M | -$1.5M | -$4.6M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · 2 Stocks to Buy Hand Over Fist in October
2026-10-05 · 5 Stocks With Recent Price Strength After a Mixed September
2026-10-01 · Bet on These 4 Stocks With Strong Net Profit Margins to Boost Returns
2026-09-28 · Here's What Could Help Nutex Health (NUTX) Maintain Its Recent Price Strength
2026-09-24 · Can Nutex Health (NUTX) Stay Undervalued As Earnings Shift?
2026-09-24 · Nutex Health (NUTX) Could Be 29% Undervalued As Nasdaq Texas Listing Nears
2026-09-23 · Nutex Health Receives Approval to List on Nasdaq in Texas, New York
2026-09-22 · Nutex Health Approved for Dual Listing on Nasdaq Texas
2026-09-18 · Zacks.com featured highlights EuroDry, Vince Holding, Nutex, TXO Partners and KB Financial
2026-09-17 · 5 Stocks With Recent Price Strength Amid a Volatile September
2026-09-11 · Stock Market Leaders Often Shine, Helped By This Sign Of Liquidity Strength
2026-09-11 · Sector Update: Healthcare Stocks Flat to Higher Premarket Friday
Price (daily)
Full chart · RSI · MACD · patterns